Form EFFECT Ensysce Biosciences,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 26, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ensysce Biosciences begins final phase of opioid overdose study
- Global M&A momentum builds in 2026 as megadeals surge, but acquirers confront a new AI "winner's paradox"--Bain & Company M&A Midyear Report
- From Products to Solutions: Linuo Pharma Packaging Charts a New Global Path Through AI-Driven Intelligent Manufacturing
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
